Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diazoxide-mediated Insulin Suppression in Hyperinsulinemic Obese Men, Part III

NCT00631033 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT00631033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00631033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diazoxide-mediated Insulin Suppression in Hyperinsulinemic Obese Men, Part III
Lead sponsor
Rijnstate Hospital
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2008
Completion date
December 31, 2011
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity